This post was originally published on this site
Viatris announced earnings per share of $0.26 on revenue of $4.54B. Analysts polled by Investing.com anticipated EPS of $0.8834 on revenue of $4.39B.
Viatris shares are down 26.73% from the beginning of the year, still down 27.20% from its 52 week high of $18.86 set on December 31, 2020. They are under-performing the S&P 500 which is up 25.07% from the start of the year.
Viatris’s report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Pfizer had beat expectations on November 2 with third quarter EPS of $1.34 on revenue of $24.09B, compared to forecast for EPS of $1.08 on revenue of $22.58B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
